The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: A single institution-based study

International Journal of Clinical Oncology

Volumn 15, Issue 2, 2010, Pages 172-178

  Ohno, Hitoshi ^a   Mizumoto, Chisaki ^a,b   Otsuki, Yoshihiro ^a   Oguma, Shigeru ^a   Yoshida, Yataro ^a  

^a TAKEDA GENERAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bloodstream infection; Chemotherapy; Hematological tumors; Port related complication; Subcutaneous implantable port

Indexed keywords

ADULT; AGED; APPLICATION SITE BLEEDING; ARTICLE; BLOOD TOXICITY; BLOODSTREAM INFECTION; CANCER GROWTH; CANCER MORTALITY; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DEVICE INFECTION; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; IMPLANTABLE PORT SYSTEM; MALE; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DEVICE REMOVAL; EQUIPMENT DESIGN; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; SUBCLAVIAN VEIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950939978     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-010-0039-8     Document Type: Article

References (21)

1. M Gallieni M Pittiruti R Biffi 2008 Vascular access in oncology patients CA Cancer J Clin 58 323 346 10.3322/CA.2008.0015 18971486
2. JS Groeger AB Lucas HT Thaler, et al. 1993 Infectious morbidity associated with long-term use of venous access devices in patients with cancer Ann Intern Med 119 1168 1174 1:STN:280:DyaK2c%2FlslOqsg%3D%3D 8239247
3. RE Schwarz JS Groeger DG Coit 1997 Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis Cancer 79 1635 1640 10.1002/(SICI)1097-0142(19970415)79:8<1635::AID-CNCR30>3.0.CO;2-X 1:STN:280:DyaK2s3lvVymuw%3D%3D 9118051 (Pubitemid 27154800)
4. Y Inaba H Yamaura Y Sato, et al. 2007 Central venous access port-related complications in outpatient chemotherapy for colorectal cancer Jpn J Clin Oncol 37 951 954 10.1093/jjco/hym118 18057011 (Pubitemid 351176487)
5. J Kawamura S Nagayama A Nomura, et al. 2008 Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer Int J Clin Oncol 13 349 354 10.1007/s10147-008-0766-2 18704637
6. BH O'Neil RM Goldberg 2008 Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials Oncologist 13 1074 1083 10.1634/theoncologist.2008-0083 18922828
7. R Biffi S Pozzi A Agazzi, et al. 2004 Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients Ann Oncol 15 296 300 10.1093/annonc/mdh049 1:STN:280:DC%2BD2c%2FlvValsg%3D%3D 14760125 (Pubitemid 38262631)
8. RS Boersma KS Jie A Verbon, et al. 2008 Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies Ann Oncol 19 433 442 10.1093/annonc/mdm350 1:STN:280: DC%2BD1c7ksVWnsg%3D%3D 17962211 (Pubitemid 351325662)
9. E Johansson M Bjorkholm H Bjorvell, et al. 2004 Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study Support Care Cancer 12 99 105 10.1007/s00520-003-0558-1 14648310 (Pubitemid 38222495)
10. S Kurul P Saip T Aydin 2002 Totally implantable venous-access ports: local problems and extravasation injury Lancet Oncol 3 684 692 10.1016/S1470-2045(02)00905-1 12424071 (Pubitemid 35314912)
11. P Samaras S Dold J Braun, et al. 2008 Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients Oncology 74 237 244 10.1159/000151393 18716418
12. DG Maki DM Kluger CJ Crnich 2006 The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies Mayo Clin Proc 81 1159 1171 10.4065/81.9.1159 16970212
13. M Karthaus T Doellmann T Klimasch, et al. 2002 Central venous catheter infections in patients with acute leukemia Chemotherapy 48 154 157 10.1159/000064922 1:CAS:528:DC%2BD38XlsFOns7g%3D 12138333
14. AM Nosari G Nador A De Gasperi, et al. 2008 Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients Leuk Lymphoma 49 2148 2155 10.1080/10428190802409930 19021058
15. E Johansson P Engervall H Bjorvell, et al. 2009 Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia Support Care Cancer 17 137 143 10.1007/s00520-008-0449-6 18449573
16. I Raad H Hanna D Maki 2007 Intravascular catheter-related infections: advances in diagnosis, prevention, and management Lancet Infect Dis 7 645 657 10.1016/S1473-3099(07)70235-9 17897607 (Pubitemid 47444563)
17. LA Mermel BM Farr RJ Sherertz, et al. 2001 Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 1249 1272 10.1086/320001 1:STN:280:DC%2BD3MzpsFansw%3D%3D 11303260 (Pubitemid 32405897)
18. DS Allan R Buckstein KR Imrie 2001 Outpatient supportive care following chemotherapy for acute myeloblastic leukemia Leuk Lymphoma 42 339 346 10.3109/10428190109064590 1:CAS:528:DC%2BD3MXmtlSltL4%3D 11699398
19. TY Halim KW Song MJ Barnett, et al. 2007 Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia Ann Oncol 18 1246 1252 10.1093/annonc/mdm112 1:STN:280: DC%2BD2srovVGrsw%3D%3D 17442662 (Pubitemid 47244373)
20. O Imataki Y Tamai M Watanabe, et al. 2006 Central venous catheter-related thrombosis with infection in cancer patients-2 cases Gan To Kagaku Ryoho 33 1353 1356 16969041
21. K Tobinai T Hotta 2004 Clinical trials for malignant lymphoma in Japan Jpn J Clin Oncol 34 369 378 10.1093/jjco/hyh060 15342663 (Pubitemid 43115299)